|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0205 USD | +9.51% |
|
-13.87% | +57.69% |
| Apr. 10 | Sanuwave Health, Inc. Provides Earnings Guidance for the First Quarter 2024 | CI |
| Apr. 01 | SANUWAVE Health, Inc. Appoints Peter Sorensen as CFO | CI |
SANUWAVE Health, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 20.4 million compared to USD 16.74 million a year ago. Net loss was USD 25.81 million compared to USD 10.29 million a year ago.
Basic loss per share from continuing operations was USD 0.03 compared to USD 0.02 a year ago. Diluted loss per share from continuing operations was USD 0.03 compared to USD 0.02 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +57.69% | 23.38M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
SANUWAVE HEALTH, INC. 
